C-935788-053
Research payments
$237,439
Through program year 2019, $237,439 in research payments was reported against C-935788-053, across 73 payments, paid by Rigel Pharmaceuticals, Inc..
- Paid by
- Rigel Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $237,439 | 73 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Choi San Diego, CA Named on 12 payments
- Kerry Rogers Columbus, OH Named on 10 payments
- David Kuter Baraboo, WI Named on 9 payments
- Michael Boxer Tucson, AZ Named on 9 payments
- Marshall Mazepa Chapel Hill, NC Named on 8 payments
- Irina Murakhovskaya Woodbury, NY Named on 5 payments
- George Rodgers Salt Lake City, UT Named on 5 payments
- Jeffrey Letzer Fort Wayne, IN Named on 4 payments
- Richy Agajanian Downey, CA Named on 4 payments
- Joshua Field Milwaukee, WI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.